Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation.

Abstract:

:Activation of endothelial cells, important in processes such as angiogenesis, is regulated by cell surface receptors, including those in the tyrosine kinase (RTK) family. Receptor activity, in turn, can be modulated by phosphorylation, turnover, or proteolytic release of a soluble extracellular domain. Previously, we demonstrated that release of soluble tie-1 receptor from endothelial cells by phorbol myristate acetate (PMA) is mediated through protein kinase C and a Ca2+-dependent protease. In this study, the release of soluble tie-1 was shown to be stimulated by inflammatory cytokines and vascular endothelial growth factor (VEGF), but not by growth factors such as basic fibroblast growth factor (bFGF) or transforming growth factor alpha (TGFalpha). Release of soluble tie by tumor necrosis factor alpha (TNFalpha) or VEGF occurred within 10 minutes of stimulation and reached maximal levels within 60 minutes. Specificity was shown by fluorescence-activated cell sorting (FACS) analysis; endothelial cells exhibited a significant decrease in cell surface tie-1 expression in response to TNF, whereas expression of epidermal growth factor receptor (EGF-R) and CD31 was stable. In contrast, tie-1 expression on megakaryoblastic UT-7 cells was unaffected by PMA or TNFalpha. Sequence analysis of the cleaved receptor indicated that tie-1 was proteolyzed at the E749/S750 peptide bond in the proximal transmembrane domain. Moreover, the hydroxamic acid derivative BB-24 demonstrated dose-dependent inhibition of cytokine-, PMA-, and VEGF-stimulated shedding, suggesting that the tie-1 protease was a metalloprotease. Protease activity in a tie-1 peptide cleavage assay was (1) associated with endothelial cell membranes, (2) specifically activated in TNFalpha-treated cells, and (3) inhibited by BB-24. Additionally, proliferation of endothelial cells in response to VEGF, but not bFGF, was inhibited by BB-24, suggesting that the release of soluble tie-1 receptor plays a role in VEGF-mediated proliferation. This study demonstrated that the release of soluble tie-1 from endothelial cells is stimulated by inflammatory cytokines and VEGF through the activation of an endothelial membrane-associated metalloprotease.

journal_name

Blood

journal_title

Blood

authors

Yabkowitz R,Meyer S,Black T,Elliott G,Merewether LA,Yamane HK

subject

Has Abstract

pub_date

1999-03-15 00:00:00

pages

1969-79

issue

6

eissn

0006-4971

issn

1528-0020

journal_volume

93

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

    abstract::The blockade of platelet integrin glycoprotein (GP) IIb/IIIa is a promising new antiplatelet strategy. The binding of ligands or of the ligand-mimetic peptide RGD causes a conformational change of GP IIb/IIIa from the nonactivated to the activated state. Because several blocking agents/inhibitors are ligand-mimetics, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Peter K,Schwarz M,Ylänne J,Kohler B,Moser M,Nordt T,Salbach P,Kübler W,Bode C

    更新日期:1998-11-01 00:00:00

  • Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation")

    abstract::Recently, we described a new genetic disorder (the "hereditary hyperferritinemia-cataract syndrome") clinically characterized by the combination of elevated serum ferritin and congenital bilateral nuclear cataract, both cotransmitted as an autosomal dominant trait. In affected subjects, hyperferritinemia (ranging from...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girelli D,Corrocher R,Bisceglia L,Olivieri O,De Franceschi L,Zelante L,Gasparini P

    更新日期:1995-12-01 00:00:00

  • VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.

    abstract::The mechanisms by which tumors metastasize to sentinel and distant lymph nodes, and beyond, are poorly understood. We developed transgenic mice that overexpress vascular endothelial growth factor-C (VEGF-C) and green fluorescent protein specifically in the skin and studied the effects of chemically-induced skin carcin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021758

    authors: Hirakawa S,Brown LF,Kodama S,Paavonen K,Alitalo K,Detmar M

    更新日期:2007-02-01 00:00:00

  • Neutrophil kinetics in chronic neutropenia.

    abstract::Quantitative studies of bone marrow neutrophil pool sizes and production rates and of blood neutrophil kinetics were performed in 16 patients with chronic neutropenia without splenomegaly. Marrow netrophil cellularity was determined from a ferrokinetic estimate of marrow normoblasts and from neutrophil-erythroid ratio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Price TH,Lee MY,Dale DC,Finch CA

    更新日期:1979-09-01 00:00:00

  • RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection.

    abstract::While the interferon (IFN)-inducible double-stranded RNA (dsRNA)-dependent protein kinase PKR is reported to initiate apoptosis in some instances, the mechanism by which diverse stress stimuli activate PKR remains unknown. Now we report that RAX, the only known cellular activator for PKR, initiates PKR activation in r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-11-006817

    authors: Bennett RL,Blalock WL,Abtahi DM,Pan Y,Moyer SA,May WS

    更新日期:2006-08-01 00:00:00

  • Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein.

    abstract::Factor V (FV) deficiency is a rare bleeding disorder whose genetic basis has been described in a relatively small number of cases. Among a total of 12 genetic defects reported in severely or moderately severe deficient patients, 3 were missense mutations and in no case was the mechanism underlying the deficiency explo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1928

    authors: Duga S,Montefusco MC,Asselta R,Malcovati M,Peyvandi F,Santagostino E,Mannucci PM,Tenchini ML

    更新日期:2003-01-01 00:00:00

  • Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces.

    abstract::Fibronectin (FN) plays a role in several adhesion mediated functions including the interaction of platelets with subendothelium. We investigated the role of plasma FN in platelet adhesion and platelet thrombus formation under flow conditions. We used two different perfusion models: the annular chamber with alpha-chymo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bastida E,Escolar G,Ordinas A,Sixma JJ

    更新日期:1987-11-01 00:00:00

  • Amelioration of Sardinian beta0 thalassemia by genetic modifiers.

    abstract::Sardinian beta-thalassemia patients all are homozygotes for the same null allele in the beta-globin gene, but the clinical manifestations are extremely variable in severity. Previous studies have shown that the coinheritance of alpha-thalassemia or the presence of genetic variants that sustain fetal hemoglobin product...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-04-217901

    authors: Galanello R,Sanna S,Perseu L,Sollaino MC,Satta S,Lai ME,Barella S,Uda M,Usala G,Abecasis GR,Cao A

    更新日期:2009-10-29 00:00:00

  • Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation.

    abstract::We examined whether activated protein C (APC) reduces ischemia/reperfusion (I/R)-induced renal injury by inhibiting leukocyte activation. In a rat model, intravenous administration of APC markedly reduced I/R-induced renal dysfunction and histological changes, whereas intravenous administration of dansyl glutamylglycy...

    journal_title:Blood

    pub_type: 杂志文章,收录出版

    doi:

    authors: Mizutani A,Okajima K,Uchiba M,Noguchi T

    更新日期:2000-06-15 00:00:00

  • Localization of ADAMTS13 to the stellate cells of human liver.

    abstract::Although the chromosomal localization (9q34) of the gene encoding the human form of ADAMTS13 (a disintegrin-like and metalloproteinase with thrombospondin type-1 motifs 13) and its exclusive expression in the liver have been established, the cells that produce this enzyme are yet to be determined. We investigated the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0152

    authors: Uemura M,Tatsumi K,Matsumoto M,Fujimoto M,Matsuyama T,Ishikawa M,Iwamoto TA,Mori T,Wanaka A,Fukui H,Fujimura Y

    更新日期:2005-08-01 00:00:00

  • New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.

    abstract::We have generated a large, unique database that includes morphologic, clinical, cytogenetic, and follow-up data from 2124 patients with myelodysplastic syndromes (MDSs) at 4 institutions in Austria and 4 in Germany. Cytogenetic analyses were successfully performed in 2072 (97.6%) patients, revealing clonal abnormaliti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-082404

    authors: Haase D,Germing U,Schanz J,Pfeilstöcker M,Nösslinger T,Hildebrandt B,Kundgen A,Lübbert M,Kunzmann R,Giagounidis AA,Aul C,Trümper L,Krieger O,Stauder R,Müller TH,Wimazal F,Valent P,Fonatsch C,Steidl C

    更新日期:2007-12-15 00:00:00

  • Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

    abstract::We previously reported that RO(+) expression correlated with increased mutation, activation, and selection among human germinal center (GC) B cells. Here, we subdivided human tonsillar B cells, including IgD(-)CD38(+) GC B cells, into different fractions based on RB expression. Although each subset contained RB(+) cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-145979

    authors: Jackson SM,Harp N,Patel D,Wulf J,Spaeth ED,Dike UK,James JA,Capra JD

    更新日期:2009-04-23 00:00:00

  • Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience.

    abstract::In multiple myeloma, cytogenetic changes are important predictors of patient outcome. In this setting, the most important changes are deletion 17p, del(17p), and translocation of chromosomes 4 and 14, t(4;14), conferring a poor outcome. However, a certain degree of heterogeneity is observed in the survival of these hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-587964

    authors: Hebraud B,Magrangeas F,Cleynen A,Lauwers-Cances V,Chretien ML,Hulin C,Leleu X,Yon E,Marit G,Karlin L,Roussel M,Stoppa AM,Belhadj K,Voillat L,Garderet L,Macro M,Caillot D,Mohty M,Facon T,Moreau P,Attal M,Munshi N

    更新日期:2015-03-26 00:00:00

  • Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

    abstract::Clinical trials have been started with the aim of inducing tumor immunity by blocking the immunosuppressive action of indoleamine-2,3-dioxygenase (IDO) with the IDO2-inhibitor dextro-1-methyl-tryptophan (D-1MT). Here we show that human dendritic cells (DCs) express both IDO-1 and IDO-2, but that only IDO1 mediates try...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-10-116111

    authors: Lob S,Konigsrainer A,Schafer R,Rammensee HG,Opelz G,Terness P

    更新日期:2008-02-15 00:00:00

  • Second to none.

    abstract::In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-07-439158

    authors: Rajkumar SV

    更新日期:2012-08-23 00:00:00

  • Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes.

    abstract::Mycobacterium avium-intracellulare (MAI) is an opportunistic pathogen commonly found in acquired immunodeficiency syndrome patients, whose immune systems are severely compromised. However, normal responses to this bacterium are apparently sufficient to prevent disseminated infection because disease is rarely found unl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Blanchard DK,Michelini-Norris MB,Pearson CA,Freitag CS,Djeu JY

    更新日期:1991-05-15 00:00:00

  • Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin.

    abstract::The long form of B-cell lymphoma-x (Bcl-x(L)), an outer mitochondrial membrane protein, has been proposed to mediate the antiapoptotic action of erythropoietin on erythroid progenitor cells and to be necessary for heme synthesis in erythroblasts. Mice with conditional knockout of Bcl-x(L) (conditional bcl-x(-/-) mice)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4344

    authors: Rhodes MM,Kopsombut P,Bondurant MC,Price JO,Koury MJ

    更新日期:2005-09-01 00:00:00

  • Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.

    abstract::Multiple myeloma (MM) is associated with severe normochromic/normocytic anemia. This study demonstrates that the abnormal up-regulation of apoptogenic receptors, including both Fas ligand (L) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), by highly malignant myeloma cells is involved in the patho...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.4.1305

    authors: Silvestris F,Cafforio P,Tucci M,Dammacco F

    更新日期:2002-02-15 00:00:00

  • Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.

    abstract::We evaluated the ability of 2 human mAbs directed against TRAILR1 (HGS-ETR1) and TRAILR2 (HGS-ETR2) to kill human myeloma cells. HGS-ETR1 and HGS-ETR2 mAbs killed 15 and 9 human myeloma cell lines (HMCLs; n = 22), respectively. IL-6, the major survival and growth factor for these HMCLs, did not prevent their killing. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-12-007971

    authors: Menoret E,Gomez-Bougie P,Geffroy-Luseau A,Daniels S,Moreau P,Le Gouill S,Harousseau JL,Bataille R,Amiot M,Pellat-Deceunynck C

    更新日期:2006-08-15 00:00:00

  • Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast-conditioned medium.

    abstract::Stimulators of human erythroid burst-forming units (BFU-E) and multipotential colony-forming cells (CFU-GEMM) can be produced by a number of different cell types. A product of human peripheral blood monocytes, interleukin 1 (IL-1), was evaluated for its ability to stimulate fibroblast cultures to produce stimulators o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zucali JR,Broxmeyer HE,Dinarello CA,Gross MA,Weiner RS

    更新日期:1987-01-01 00:00:00

  • Neoplastic human T-cells capable of responding to multiple human alloantigens.

    abstract::Monoclonally-derived neoplastic T-cells from a patient with cutaneous T-cell lymphoma respond to multiple human HLA-D antigens in mixed lymphocyte culture. The implications of this phenomenon relevant to normal T-cell function and to malignancy are discussed. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rubenfeld MR,Edelson RL,Löfström LM,Berger CL,Warburton D

    更新日期:1980-03-01 00:00:00

  • Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.

    abstract::Childhood acute myeloid leukemia (AML) has a poor prognosis with standard chemotherapy. Allogeneic bone marrow transplantation (BMT) in remission improves the outlook only for the one third of patients with sibling donors. Autologous BMT with a lower morbidity and mortality is available to all. In this study, maximum ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tiedemann K,Waters KD,Tauro GP,Tucker D,Ekert H

    更新日期:1993-12-15 00:00:00

  • Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

    abstract::The survival of patients with aggressive non-Hodgkin lymphoma (NHL) is increasing, but the incidence of secondary cancer and late toxicity is poorly defined for those treated with cyclophosphamide-hydroxydaunomycin/doxorubicin-Oncovin-prednisone (CHOP)-like chemotherapy. From February 1984 to January 1998, 2837 patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1124

    authors: André M,Mounier N,Leleu X,Sonet A,Brice P,Henry-Amar M,Tilly H,Coiffier B,Bosly A,Morel P,Haioun C,Gaulard P,Reyes F,Gisselbrecht C,Groupe D'Etude Des Lymphomes De L'Adulte.

    更新日期:2004-02-15 00:00:00

  • The tetraspanin CD63 is involved in granule targeting of neutrophil elastase.

    abstract::Targeting mechanisms of neutrophil elastase (NE) and other luminal proteins stored in myeloperoxidase (MPO)-positive secretory lysosomes/primary granules of neutrophils are unknown. These granules contain an integral membrane protein, CD63, with an adaptor protein-3-dependent granule delivery system. Therefore, we hyp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-10-116285

    authors: Källquist L,Hansson M,Persson AM,Janssen H,Calafat J,Tapper H,Olsson I

    更新日期:2008-10-15 00:00:00

  • The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells.

    abstract::The role of hematopoietic growth factors in lineage commitment and differentiation is unclear. We present evidence that heterologous expression of an erythroid specific receptor allows granulocytic differentiation of a myeloid cell line. We have previously characterized a truncation mutant of the erythropoietin recept...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Harris KW,Hu XJ,Schultz S,Arcasoy MO,Forget BG,Clare N

    更新日期:1998-08-15 00:00:00

  • Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.

    abstract::Reconstitution of cytomegalovirus (CMV)-specific CD8(+) T cells is essential to the control of CMV infection in CMV-positive recipients (R(+)) after allogeneic hematopoietic stem cell transplantation (HCT). Six-color flow cytometry was used to assess the functional profile of CMV-specific CD8(+) T cells in 62 of 178 R...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-203307

    authors: Zhou W,Longmate J,Lacey SF,Palmer JM,Gallez-Hawkins G,Thao L,Spielberger R,Nakamura R,Forman SJ,Zaia JA,Diamond DJ

    更新日期:2009-06-18 00:00:00

  • Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

    abstract::The molecular backgrounds of variants encountered in Afro-Caribbean black individuals and associated with the production of clinically significant antibodies against high-incidence antigens (anti-RH18, anti-RH34) and against Rhe epitopes were determined. We showed that RH:-18 phenotypes are produced by 3 distinct RHCE...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0229

    authors: Noizat-Pirenne F,Lee K,Pennec PY,Simon P,Kazup P,Bachir D,Rouzaud AM,Roussel M,Juszczak G,Ménanteau C,Rouger P,Kotb R,Cartron JP,Ansart-Pirenne H

    更新日期:2002-12-01 00:00:00

  • A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.

    abstract::This article reports a Glanzmann thrombasthenia (GT) patient, N.M., with a point mutation in the third cysteine-rich repeat of beta3-integrin or platelet glycoprotein (GP) IIIa, leading to the expression of a constitutively activated fibrinogen receptor. The diagnosis of GT was based on a severely reduced platelet-agg...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.8.2432

    authors: Ruiz C,Liu CY,Sun QH,Sigaud-Fiks M,Fressinaud E,Muller JY,Nurden P,Nurden AT,Newman PJ,Valentin N

    更新日期:2001-10-15 00:00:00

  • Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences.

    abstract::In patients with common variable immunodeficiency (CVI), we have previously defined a subgroup of patients (CVIHyper) characterized by decreased numbers of CD4+ lymphocytes in peripheral blood, splenomegaly, and persistent immune activation in vivo, particularly of monocytes/macrophages. To further characterize this h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Aukrust P,Lien E,Kristoffersen AK,Müller F,Haug CJ,Espevik T,Frøland SS

    更新日期:1996-01-15 00:00:00

  • BuMPing iron with modified heparins.

    abstract::In this issue of Blood, Poli et al demonstrate that heparin analogs engineered to minimize their anticoagulant properties can potently downregulate hepcidin production in vitro and in vivo, and may potentially be used to treat the anemia of inflammation. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-01-549519

    authors: Babitt JL,Lin HY

    更新日期:2014-03-06 00:00:00